PT-141 30mg — Vial Spec, Reconstitution Math & COA

Technical Overview & Mass Specification of PT-141 30mg

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analog of the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (α-MSH). Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, PT-141 possesses a molecular weight of approximately 1024.2 g/mol. A 30mg unit specification contains thirty milligrams of pure, lyophilized peptide cake formulated with precise buffer salts to preserve structural integrity during cold-chain transport and storage.

While PX1 Research currently supplies standard single-protocol formats such as the PT-141 10mg vial, understanding the chemical dynamics of a 30mg format is critical for laboratories operating automated pipetting stations or conducting high-volume comparative bioassays. Investigators seeking alternative fill sizes or related compounds can review our complete catalog of ultra-pure all peptides to align mass requirements with specific assay throughput targets.

Receptor Signaling Dynamics and Preclinical Research Focus

PT-141 acts primary as a non-selective agonist across central melanocortin receptors, displaying pronounced affinity for the melanocortin-4 receptor (MC4R) and melanocortin-3 receptor (MC3R), with variable binding across MC1R and MC5R. Unlike conventional peripheral vasodilatory agents, PT-141 operates directly within the central nervous system, binding to hypothalamic receptors that modulate downstream neuroendocrine and autonomic signaling pathways.

Preclinical studies suggest that central activation of MC4R by PT-141 initiates cascade mechanisms involving dopamine transmission in the medial preoptic area (mPOA). Consequently, the compound is heavily investigated for melanocortin-receptor signaling linked to sexual-health pathways, central appetite regulation, and neuroprotective pathways in rodent and non-human primate models. In vitro assays utilize PT-141 to map signal transduction, cyclic adenosine monophosphate (cAMP) accumulation, and receptor internalization kinetics.

Reconstitution Mathematics for 30mg Lyophilized Vials

Reconstitution of a 30mg lyophilized cake requires precise volumetric calculation to achieve target concentrations suitable for micro-pipetting. Because 30mg represents a higher total peptide mass than standard laboratory units, selecting the appropriate volume of sterile diluent—such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride—is paramount for maintaining solubilization without exceeding vial fluid capacities.

Below are standard concentration parameters when adding common diluent volumes to a 30mg PT-141 vial:

1.0 mL Diluent Addition: Yields a stock concentration of 30.0 mg/mL (30.0 µg/µL). This hyper-concentrated stock is suitable for primary freeze-aliquot preservation where minimal storage volume is required.

2.0 mL Diluent Addition: Yields a stock concentration of 15.0 mg/mL (15.0 µg/µL). Provides a manageable working concentration for multi-plate serial dilutions.

3.0 mL Diluent Addition: Yields a stock concentration of 10.0 mg/mL (10.0 µg/µL). Highly convenient for volumetric dispensing into working assay buffers.

5.0 mL Diluent Addition: Yields a stock concentration of 6.0 mg/mL (6.0 µg/µL). Optimal for automated liquid handlers requiring larger working fluid margins.

Researchers can utilize the PX1 interactive reconstitution calculator to determine exact volumetric requirements based on custom working concentrations and micro-pipette accuracy parameters.

Aliquot Planning and Degradation Mitigations

Reconstituting a 30mg vial produces a substantial volume of active solution. Repeated freeze-thaw cycles subject the peptide's cyclic disulfide ring structure to mechanical stress, accelerating peptide bond cleavage and irreversible aggregation. To maintain compound fidelity over extended study timelines, laboratories must execute a strict aliquoting protocol immediately following primary reconstitution.

Upon introducing diluent, gently swirl the vial until the lyophilized cake fully dissolves; never vortex or vigorously agitate the peptide matrix. Using sterile micro-centrifuge tubes (polypropylene, low-binding), split the master solution into single-use volumetric fractions (e.g., 50 µL or 100 µL aliquots). Flash-freeze secondary aliquots in liquid nitrogen or ultra-low temperature freezers (-80°C) and thaw only the immediate aliquot required for each individual assay run.

Comparative Analysis: PT-141 vs. Related Melanocortin Agonists

When designing melanocortin signaling assays, researchers frequently contrast PT-141 with structurally related analogs to evaluate receptor subtype selectivity and metabolic half-life in cell cultures. As a synthetic derivative, PT-141 omits the C-terminal amide sequence found in its predecessor Melanotan II, which significantly alters its receptor binding profile—reducing peripheral MC1R activity while preserving potent central MC4R stimulation.

Compared to endogenous Alpha-MSH, which displays rapid enzymatic degradation by circulating endopeptidases, PT-141 exhibits enhanced structural stability due to its cyclic design. This structural resistance prolongs signaling activation in cell-based assays, allowing researchers to study long-term receptor internalization and downstream gene transcription without continuous re-dosing of candidate peptides.

Analytical Quality Standards & COA Verification

Analytical precision is the foundational baseline for all valid scientific research. Peptides containing residual synthesis reagents, trifluoroacetic acid (TFA) salts, or truncated sequence impurities can produce false-positive cellular responses or mask subtle receptor binding kinetics. Therefore, every lot distributed for laboratory research must undergo rigorous chemical validation.

PX1 Research enforces strict quality assurance standards using third-party verification. Each production lot undergoes High-Performance Liquid Chromatography (HPLC) to verify chemical purity (guaranteed ≥98%) and Mass Spectrometry (MS) to confirm exact molecular mass (1024.2 Da). Additionally, bacterial endotoxin testing (LAL assay) ensures levels remain strictly below <0.01 EU/µg to prevent non-specific immune activation in cell culture models. Researchers can review batch-specific data directly on our dedicated COA hub.

Storage and Stability Guidelines for Laboratory Facilities

Proper storage conditions are critical to preserve the functional potency of PT-141 30mg vials over extended research periods. Unreconstituted (lyophilized) vials should be kept desiccated at -20°C for long-term storage (up to 24 months) or 2°C to 8°C for short-term benchtop storage (up to 90 days), shielded from direct light exposure.

Once reconstituted with bacteriostatic diluents, liquid stock solutions remain stable at refrigerated temperatures (2°C to 8°C) for up to 28 days. If reconstituted using non-preserved sterile 0.9% saline, the solution must be used within 24 hours or frozen immediately. Avoid storing liquid solutions in frost-free freezers, as temperature fluctuations during automatic defrost cycles accelerate peptide degradation.

Selecting Unit Mass: 10mg vs. 30mg Formats

Choosing between smaller format units such as the PT-141 10mg vial and larger 30mg bulk configurations depends on experimental design, assay volume, and equipment setup. Single 10mg vials are ideal for low-throughput studies or short-term protocols where fresh reconstitution eliminates degradation risks across minor assay breaks.

Conversely, high-volume automated screening facilities, structural biology groups, or multi-animal cohort studies benefit from 30mg configurations by reducing batch-to-batch variation across large experimental groups. Academic and commercial institutions planning high-volume research protocols can establish dedicated supply channels through our wholesale lab accounts program, ensuring consistent batch allocations and direct lot-matched analytical documentation.